| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/03/2008 | US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier |
| 07/03/2008 | US20080159981 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 07/03/2008 | US20080159964 As polymer conjugates; reduced side effects; inhalation formulations and kits |
| 07/03/2008 | US20080159963 drug delivery device for wound irrigation, has reservoir housings containing water and chlorhexidine solution, and discharge nozzles; pressurized flow; used to treat a wound in the human skin and disinfection |
| 07/03/2008 | US20080159962 administering Angiotensin Converting enzyme 2 (ACE2) for treating infection with acute respiratory Syndrome (SARS) Coronavirus; including AT1-inhibitor, AT2-agonist, a bradykinin receptor inhibitor, a renin inhibitor and/or an ACE inhibitor |
| 07/03/2008 | US20080159961 Pharmaceutical Composition |
| 07/03/2008 | US20080159959 antiinflammatory agents has water-soluble N-(2-hydroxypropyl) methacrylamide copolymer linked to a glucocorticoid; drug conjugated with a polymer for targeting to bone or cartilage tissue; treatment of rheumatoid arthritis using MR imaging techniques |
| 07/03/2008 | US20080156821 Topical preparation dispensers and methods of using the same |
| 07/03/2008 | US20080156228 Pigment of nanopowders of vanadium and an additional element; exhibiting transparency to a visible wavelength of light that differs by more than 20%; nanopowders having a domain size of less than 100 nanometers |
| 07/03/2008 | US20080155853 Powder formation by atmospheric spray-freeze drying |
| 07/03/2008 | DE112005000730T5 Ionen bindende Polymere und ihre Verwendung Ion-binding polymers and their use |
| 07/03/2008 | CA2710284A1 Coatings for implantable medical devices for liposome delivery |
| 07/03/2008 | CA2709428A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | CA2707100A1 Morpholino compound microemulsion |
| 07/03/2008 | CA2674776A1 Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
| 07/03/2008 | CA2674128A1 Self-microemulsifying drug delivery systems |
| 07/03/2008 | CA2673638A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | CA2673627A1 Ciclesonide containing sterile aqueous suspension |
| 07/03/2008 | CA2673622A1 Lipid |
| 07/03/2008 | CA2673536A1 Revaprazan-containing solid dispersion and process for the preparation thereof |
| 07/03/2008 | CA2673525A1 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 07/03/2008 | CA2673511A1 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 07/03/2008 | CA2673458A1 Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients |
| 07/03/2008 | CA2673294A1 Processes for making cyclic lipid implants for intraocular use |
| 07/03/2008 | CA2673260A1 Factor vii and viia compositions |
| 07/03/2008 | CA2673228A1 Disintegration promoters in solid dose wet granulation formulations |
| 07/03/2008 | CA2673194A1 Treated substrates having improved delivery of impregnated ingredients |
| 07/03/2008 | CA2673049A1 Stable anti-nausea oral spray formulations and methods |
| 07/03/2008 | CA2672402A1 Solid dispersion of a neurokinin antagonist |
| 07/03/2008 | CA2670715A1 Nanoemulsion comprising aqueous components |
| 07/03/2008 | CA2667072A1 Gel useful for the delivery of ophthalmic drugs |
| 07/02/2008 | EP1939290A2 Gene expression control |
| 07/02/2008 | EP1938862A2 Disordered breathing management system and methods |
| 07/02/2008 | EP1938842A1 Method for preparation of pharmaceutical composition having improved disintegradability |
| 07/02/2008 | EP1938840A1 Duloxetine composition |
| 07/02/2008 | EP1938822A1 Combination therapy for the treatment of airways disease |
| 07/02/2008 | EP1938821A2 Methods of administering epothilone analogs for the treatment of cancer |
| 07/02/2008 | EP1938809A1 Adhesive skin patch |
| 07/02/2008 | EP1938808A1 Preparation for external use |
| 07/02/2008 | EP1938807A1 Reactive powdering |
| 07/02/2008 | EP1938806A1 Buccal drug delivery |
| 07/02/2008 | EP1938805A1 Monolithic sustained release zolpidem tablets |
| 07/02/2008 | EP1938804A1 Pharmaceutical formulation comprising neurokinin antagonist |
| 07/02/2008 | EP1938803A2 Formulations comprising nanoparticulate meloxican |
| 07/02/2008 | EP1938802A1 Interfering RNAs targeting pro-inflammatory cytokines |
| 07/02/2008 | EP1938801A1 Nanoemulsion |
| 07/02/2008 | EP1938800A1 Sirolimus nanodispersion |
| 07/02/2008 | EP1938799A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 07/02/2008 | EP1938798A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 07/02/2008 | EP1937753A1 Thermoset particles and methods for production thereof |
| 07/02/2008 | EP1937414A2 Oramucosal pharmaceutical dosage form |
| 07/02/2008 | EP1937327A1 Natural biodegradable matrices and uses thereof |
| 07/02/2008 | EP1937326A1 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 07/02/2008 | EP1937284A1 Microbicidal dendrimer composition delivery system |
| 07/02/2008 | EP1937282A1 Chitosan and heparin nanoparticles |
| 07/02/2008 | EP1937276A2 Improved testosterone gel and method of use |
| 07/02/2008 | EP1937253A2 Combined preparation of o-acetylsalicylic acid salts |
| 07/02/2008 | EP1937229A2 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions |
| 07/02/2008 | EP1937228A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 07/02/2008 | EP1937227A1 Transdermal therapeutic system for administering lipophilic and/or cutaneous low-permeable active substances |
| 07/02/2008 | EP1937226A2 Transdermal galantamine delivery system |
| 07/02/2008 | EP1937225A2 Coated substrate with properties of keratinous tissue |
| 07/02/2008 | EP1937224A2 Skincare products |
| 07/02/2008 | EP1937223A1 Sustained-release pellet formulation of alpha1-receptor antagonist and process for the preparation thereof |
| 07/02/2008 | EP1937222A1 New sustained-release multiple unit dosage form |
| 07/02/2008 | EP1937221A1 Retard formulation for pralnacasan |
| 07/02/2008 | EP1937220A2 Ramipril formulation with increased stability |
| 07/02/2008 | EP1937219A2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| 07/02/2008 | EP1937218A2 Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
| 07/02/2008 | EP1937217A2 Nanoparticulate tadalafil formulations |
| 07/02/2008 | EP1937216A1 Pharmaceutical composition comprising perindopril or its salts |
| 07/02/2008 | EP1937215A2 Pharmaceutical composition comprising an iron chelator |
| 07/02/2008 | EP1937214A2 Method of storing nanoparticle formulations |
| 07/02/2008 | EP1937213A1 Systems and methods for manufacturing liposomes |
| 07/02/2008 | EP1937212A2 Ophthalmic emulsions containing prostaglandins |
| 07/02/2008 | EP1937211A2 Surfactant systems for delivery of organic compounds |
| 07/02/2008 | EP1937210A2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 07/02/2008 | EP1825861A4 Anti-inflammatory extract and agent and method for the production thereof |
| 07/02/2008 | EP1802250A4 Methods of treating wounds with gonyautoxins |
| 07/02/2008 | EP1732515B1 Dry powder preparations for pre-metered dpi |
| 07/02/2008 | EP1729819B1 X-ray visible drug delivery device |
| 07/02/2008 | EP1713447A4 Particulate plant sterol compositions |
| 07/02/2008 | EP1691787B1 Method for making pharmaceutical multiparticulates |
| 07/02/2008 | EP1680076B1 Pharmaceutical and cosmetic formulations for treating fingernails |
| 07/02/2008 | EP1635791B1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 07/02/2008 | EP1631375A4 Injectable hydrogel microspheres from aqueous two-phase system |
| 07/02/2008 | EP1610768B1 Matrix compositions for controlled delivery of drug substances |
| 07/02/2008 | EP1592451B1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound |
| 07/02/2008 | EP1539166B1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/02/2008 | EP1487791B1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate |
| 07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/02/2008 | EP1366455B1 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 07/02/2008 | EP1328273B1 Felodipine transdermal device and methods |
| 07/02/2008 | EP1282404B1 Method for preparing microparticles having a selected polymer molecular weight |
| 07/02/2008 | EP1265579B1 Container for linezolid intravenous solution |
| 07/02/2008 | EP1251818B1 Galenic formulation |
| 07/02/2008 | EP1200091B1 Pharmaceutical composition comprising tadalafil |
| 07/02/2008 | EP1165057B1 Endodontic fibers and methods of use therefor |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP1094781B1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |